PMID- 25449839 OWN - NLM STAT- MEDLINE DCOM- 20150820 LR - 20220408 IS - 1872-7549 (Electronic) IS - 0166-4328 (Print) IS - 0166-4328 (Linking) VI - 279 DP - 2015 Feb 15 TI - Multiple faces of BDNF in cocaine addiction. PG - 240-54 LID - S0166-4328(14)00747-5 [pii] LID - 10.1016/j.bbr.2014.11.018 [doi] AB - Brain-derived neurotrophic factor (BDNF) has been found to play roles in many types of plasticity including drug addiction. Here, we focus on rodent studies over the past two decades that have demonstrated diverse roles of BDNF in models of cocaine addiction. First, we will provide an overview of studies showing that cocaine exposure alters (and generally increases) BDNF levels in reward-related regions including the ventral tegmental area, nucleus accumbens, prefrontal cortex, and amygdala. Then we will review evidence that BDNF contributes to behavioral changes in animal models of cocaine addiction, focusing on conditioned place preference, behavioral sensitization, maintenance and reinstatement of self-administration, and incubation of cocaine craving. Last, we will review the role of BDNF in synaptic plasticity, particularly as it relates to plasticity of AMPA receptor transmission after cocaine exposure. We conclude that BDNF regulates cocaine-induced behaviors in a highly complex manner that varies depending on the brain region (and even among different cell types within the same brain region), the nature of cocaine exposure, and the "addiction phase" examined (e.g., acquisition vs maintenance; early vs late withdrawal). These complexities make BDNF a daunting therapeutic target for treating cocaine addiction. However, recent clinical evidence suggests that the serum BDNF level may serve as a biomarker in cocaine addicts to predict future relapse, providing an alternative direction for exploring BDNF's potential relevance to treating cocaine addiction. CI - Copyright (c) 2014 Elsevier B.V. All rights reserved. FAU - Li, Xuan AU - Li X AD - Behavioral Neuroscience Research Branch, Intramural Research Program, NIDA/NIH/DHHS, Baltimore, MD, USA. Electronic address: anna.li@nih.gov. FAU - Wolf, Marina E AU - Wolf ME AD - Department of Neuroscience, Rosalind Franklin University of Medicine and Science, North Chicago, IL, USA. LA - eng GR - R01 DA009621/DA/NIDA NIH HHS/United States GR - K05 DA029099/DA/NIDA NIH HHS/United States GR - R01 DA015835/DA/NIDA NIH HHS/United States GR - DA009621/DA/NIDA NIH HHS/United States GR - DA015835/DA/NIDA NIH HHS/United States GR - R37 DA015835/DA/NIDA NIH HHS/United States GR - DA029099/DA/NIDA NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Review DEP - 20141115 PL - Netherlands TA - Behav Brain Res JT - Behavioural brain research JID - 8004872 RN - 0 (Brain-Derived Neurotrophic Factor) RN - 0 (Receptors, AMPA) RN - I5Y540LHVR (Cocaine) SB - IM MH - Animals MH - Brain/drug effects/*metabolism MH - Brain-Derived Neurotrophic Factor/*metabolism/*physiology MH - Cocaine/administration & dosage MH - Cocaine-Related Disorders/*metabolism MH - Conditioning, Psychological/drug effects/physiology MH - Corpus Striatum/drug effects/metabolism MH - Craving/drug effects/physiology MH - Disease Models, Animal MH - Mice MH - Neuronal Plasticity/drug effects MH - Rats MH - Receptors, AMPA/metabolism MH - Reward MH - Self Administration PMC - PMC4277902 MID - NIHMS642907 OTO - NOTNLM OT - AMPA receptor. OT - BDNF OT - Cocaine addiction OT - TrkB COIS- Conflict of interest: The authors report no biomedical financial interests or potential conflicts of interest. EDAT- 2014/12/03 06:00 MHDA- 2015/08/21 06:00 PMCR- 2016/02/15 CRDT- 2014/12/03 06:00 PHST- 2014/09/04 00:00 [received] PHST- 2014/11/04 00:00 [revised] PHST- 2014/11/08 00:00 [accepted] PHST- 2014/12/03 06:00 [entrez] PHST- 2014/12/03 06:00 [pubmed] PHST- 2015/08/21 06:00 [medline] PHST- 2016/02/15 00:00 [pmc-release] AID - S0166-4328(14)00747-5 [pii] AID - 10.1016/j.bbr.2014.11.018 [doi] PST - ppublish SO - Behav Brain Res. 2015 Feb 15;279:240-54. doi: 10.1016/j.bbr.2014.11.018. Epub 2014 Nov 15.